YANKCOM Partnership »

Aquestive Therapeutics shares owned by YANKCOM Partnership

Quarter-by-quarter ownership of Aquestive Therapeutics (AQST) shares owned by YANKCOM Partnership from 13F filings

Historical chart of YANKCOM Partnership investment in Aquestive Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aquestive Therapeutics held by YANKCOM Partnership consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aquestive Therapeutics by YANKCOM Partnership

Quarter filed Position value Share count Share price at filing
2025-12-31 $3.9k 600 6.46

More positions owned by YANKCOM Partnership

Vanguard FTSE Developed Markets ETF Van Ftse Dev Mkt (VEA)
Vanguard Index Funds S&P 500 ETF S&p 500 Etf Shs (VOO)
Schwab Strategic Tr US Large-Cap Value ETF Us Lcap Va Etf (SCHV)
iShares Tr S&P Midcap 400 ETF Core S&p Mcp Etf (IJH)
iShares Tr Russell Top 200 Growth ETF Rus Tp200 Gr Etf (IWY)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
NVIDIA Corporation (NVDA)
Alphabet Inc Cap Stock Cl A Cap Stk Cl A (GOOGL)
Vanguard FTSE Emerging Markets ETF Ftse Emr Mkt Etf (VWO)
SPDR Portfolio Developed World Ex-US ETF Portfolio Devlpd (SPDW)
Citigroup Com New (C)
JPMorgan Chase & Co. (JPM)
Broadcom (AVGO)

View all positions for YANKCOM Partnership

Top funds holding Aquestive Therapeutics

Bratton Capital Management
BlackRock
Rtw Investments
Vanguard Group
Perceptive Advisors
EcoR1 Capital
Samsara BioCapital
Geode Capital Management
State Street Corporation
Sio Capital Management
Susquehanna International
Millennium Management
Blue Owl Capital Holdings
Janney Montgomery Scott
Commonwealth Equity Services

View all funds holding Aquestive Therapeutics